Sandra Milligan

Insider Reports History

Location
2000 Galloping Hill Road, Kenilworth, NJ
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandra Milligan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Organon & Co. Head of Research & Development Common Stock 28.6K $616K $21.53 May 4, 2023 Direct
Gossamer Bio, Inc. Director Common Stock 58.1K $111K $1.92 Aug 19, 2025 Direct
Organon & Co. Head of Research & Development Restricted Stock Units 4.98K $107K $21.53 May 4, 2023 Direct
Aspira Women's Health Inc. Interim CEO Stock option (right to buy) 25K $96K $3.20 Nov 12, 2024 Direct
Aspira Women's Health Inc. Interim CEO Common Stock 13.6K $9.55K $0.70 Jan 8, 2025 Direct
Aspira Women's Health Inc. Interim CEO Restricted Stock Units 0 $0 $2.42 Dec 31, 2024 Direct
Gossamer Bio, Inc. Director Stock Option (Right to Buy) 115K Jun 25, 2025 Direct
Spyre Therapeutics, Inc. Director Stock Option (Right to Buy) 25K May 29, 2025 Direct

Insider Reports Filed by Sandra Milligan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GOSS Gossamer Bio, Inc. Aug 19, 2025 1 $50K 4 Aug 20, 2025 Director
GOSS Gossamer Bio, Inc. Jun 25, 2025 1 $0 4 Jun 26, 2025 Director
SYRE Spyre Therapeutics, Inc. May 29, 2025 1 $0 4 Jun 2, 2025 Director
AWH Aspira Women's Health Inc. Dec 31, 2024 3 -$4.45K 4/A Jan 29, 2025 Interim CEO
AWH Aspira Women's Health Inc. Nov 12, 2024 1 $0 4 Nov 13, 2024 President
AWH Aspira Women's Health Inc. Oct 28, 2024 1 $0 4 Oct 28, 2024 President
GOSS Gossamer Bio, Inc. Jun 6, 2024 1 $0 4 Jun 6, 2024 Director
SYRE Spyre Therapeutics, Inc. May 14, 2024 1 $0 4 May 16, 2024 Director
SYRE Spyre Therapeutics, Inc. May 14, 2024 0 $0 3 May 16, 2024 Director
AWH Aspira Women's Health Inc. May 3, 2024 1 $0 4 May 6, 2024 President
AWH Aspira Women's Health Inc. Apr 1, 2024 0 $0 3 Apr 4, 2024 President
GOSS Gossamer Bio, Inc. Nov 15, 2023 1 $25.2K 4 Nov 17, 2023 Director
GOSS Gossamer Bio, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
OGN Organon & Co. May 4, 2023 3 -$52.6K 4 May 8, 2023 Head of Research & Development
OGN Organon & Co. May 1, 2023 3 -$20.3K 4 May 3, 2023 Head of Research & Development
OGN Organon & Co. Mar 31, 2023 5 -$48.8K 4 Apr 4, 2023 Head of Research & Development
OGN Organon & Co. Feb 28, 2023 3 -$58.9K 4 Mar 2, 2023 Head of Research & Development
GOSS Gossamer Bio, Inc. Jun 9, 2022 1 $0 4 Jul 15, 2022 Director
OGN Organon & Co. May 3, 2022 6 -$75.4K 4 May 5, 2022 Head of Research & Development
OGN Organon & Co. May 1, 2022 3 -$17.5K 4 May 3, 2022 Head of Research & Development
OGN Organon & Co. Mar 31, 2022 2 $0 4 Apr 4, 2022 Head of Research & Development
OGN Organon & Co. Feb 28, 2022 3 -$110K 4 Mar 2, 2022 Head of Research & Development
OGN Organon & Co. Aug 17, 2021 1 $0 4 Aug 19, 2021 Head of Research & Development
GOSS Gossamer Bio, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
GOSS Gossamer Bio, Inc. Jun 10, 2021 0 $0 3 Jun 14, 2021 Director
OGN Organon & Co. Jun 2, 2021 12 $0 4 Jun 4, 2021 Head of Research & Development
OGN Organon & Co. Jun 2, 2021 0 $0 3 Jun 2, 2021 Head of Research & Development